These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 1834644)
41. Natural and recombinant human IL-1 receptor antagonists block the effects of IL-1 on bone resorption and prostaglandin production. Seckinger P; Klein-Nulend J; Alander C; Thompson RC; Dayer JM; Raisz LG J Immunol; 1990 Dec; 145(12):4181-4. PubMed ID: 2147937 [TBL] [Abstract][Full Text] [Related]
42. Human recombinant interleukin-1 receptor antagonist inhibits lymphocyte blastogenesis induced by concanavalin A. Restorative effect of hrIL-1. Conti P; Reale M; Panara MR; Barbacane RC; Bongrazio M; Dempsey RA FEBS Lett; 1991 Jul; 286(1-2):137-41. PubMed ID: 1830851 [TBL] [Abstract][Full Text] [Related]
43. Differences in internalization and intracellular processing of interleukin-1 associated with the two forms of interleukin-1 receptor found in B-cells and T-cells. Horuk R Biochem J; 1991 Jan; 273(Pt 1)(Pt 1):79-83. PubMed ID: 1824916 [TBL] [Abstract][Full Text] [Related]
44. Role of IL-18 in the secretion of Il-1beta, sIL-1RII, and IL-1Ra by human neutrophils. Jablonska E; Izycka A; Jablonska J; Wawrusiewicz N; Piecuch J Immunol Invest; 2001 Aug; 30(3):221-9. PubMed ID: 11570642 [TBL] [Abstract][Full Text] [Related]
45. Identification of a high-affinity receptor for native human interleukin 1 beta and interleukin 1 alpha on normal human lung fibroblasts. Chin J; Cameron PM; Rupp E; Schmidt JA J Exp Med; 1987 Jan; 165(1):70-86. PubMed ID: 2947968 [TBL] [Abstract][Full Text] [Related]
46. Conversion of the interleukin 1 receptor antagonist into an agonist by site-specific mutagenesis. Ju G; Labriola-Tompkins E; Campen CA; Benjamin WR; Karas J; Plocinski J; Biondi D; Kaffka KL; Kilian PL; Eisenberg SP Proc Natl Acad Sci U S A; 1991 Apr; 88(7):2658-62. PubMed ID: 1826365 [TBL] [Abstract][Full Text] [Related]
47. Compartmentalization of the inflammatory response to inhaled grain dust. Becker S; Clapp WA; Quay J; Frees KL; Koren HS; Schwartz DA Am J Respir Crit Care Med; 1999 Oct; 160(4):1309-18. PubMed ID: 10508823 [TBL] [Abstract][Full Text] [Related]
48. The specific IL-1 inhibitor from the human M20 cell line is distinct from the IL-1 receptor antagonist. Barak V; Peritt D; Flechner I; Yanai P; Halperin T; Treves AJ; Dinarello CA Lymphokine Cytokine Res; 1991 Dec; 10(6):437-42. PubMed ID: 1839505 [TBL] [Abstract][Full Text] [Related]
50. Evidence for different interleukin 1 receptors in murine B- and T-cell lines. Bomsztyk K; Sims JE; Stanton TH; Slack J; McMahan CJ; Valentine MA; Dower SK Proc Natl Acad Sci U S A; 1989 Oct; 86(20):8034-8. PubMed ID: 2530580 [TBL] [Abstract][Full Text] [Related]
51. Generation and characterization of a human monoclonal autoantibody that acts as a high affinity interleukin-1 alpha specific inhibitor. Garrone P; Djossou O; Fossiez F; Reyes J; Ait-Yahia S; Maat C; Ho S; Hauser T; Dayer JM; Greffe J; Miossec P; Lebecque S; Rousset F; Banchereau J Mol Immunol; 1996; 33(7-8):649-58. PubMed ID: 8760277 [TBL] [Abstract][Full Text] [Related]
52. Effects of eleven cytokines and of IL-1 and tumor necrosis factor inhibitors in a human B cell assay. Tucci A; James H; Chicheportiche R; Bonnefoy JY; Dayer JM; Zubler RH J Immunol; 1992 May; 148(9):2778-84. PubMed ID: 1315359 [TBL] [Abstract][Full Text] [Related]
53. Reduced mitogen stimulation of DNA synthesis in human lymphocytes by a human recombinant interleukin-1 receptor antagonist. Conti P; Reale M; Barbacane RC; Panara MR; Bongrazio M; Dempsey RA; Dinarello CA Immunol Lett; 1991 Apr; 28(1):19-25. PubMed ID: 1830027 [TBL] [Abstract][Full Text] [Related]
54. Expression of IL-1 receptors on human peripheral B cells. Tanaka Y; Shirakawa F; Oda S; Eto S; Yamashita U J Immunol; 1989 Jan; 142(1):167-72. PubMed ID: 2521232 [TBL] [Abstract][Full Text] [Related]
55. Induction of interleukin-1 receptor antagonist (IL-1ra) following surgery is associated with major trauma. O'Nualláin EM; Puri P; Mealy K; Reen DJ Clin Immunol Immunopathol; 1995 Jul; 76(1 Pt 1):96-101. PubMed ID: 7606873 [TBL] [Abstract][Full Text] [Related]
56. Autocrine interleukin-1 receptor antagonist can support malignant growth of glioblastoma by blocking growth-inhibiting autocrine loop of interleukin-1. Oelmann E; Kraemer A; Serve H; Reufi B; Oberberg D; Patt S; Herbst H; Stein H; Thiel E; Berdel WE Int J Cancer; 1997 Jun; 71(6):1066-76. PubMed ID: 9185713 [TBL] [Abstract][Full Text] [Related]
57. Interleukin 1 induces NF-kappa B through its type I but not its type II receptor in lymphocytes. Stylianou E; O'Neill LA; Rawlinson L; Edbrooke MR; Woo P; Saklatvala J J Biol Chem; 1992 Aug; 267(22):15836-41. PubMed ID: 1386364 [TBL] [Abstract][Full Text] [Related]
59. The interleukin-1 receptor in Raji human B-lymphoma cells. Molecular characterization and evidence for receptor-mediated activation of gene expression. Horuk R; McCubrey JA Biochem J; 1989 Jun; 260(3):657-63. PubMed ID: 2527495 [TBL] [Abstract][Full Text] [Related]
60. Secretion of IL-1 beta, TNF-alpha, IL-8 and IL-1ra by human polymorphonuclear leukocytes in response to lipopolysaccharides from periodontopathic bacteria. Yoshimura A; Hara Y; Kaneko T; Kato I J Periodontal Res; 1997 Apr; 32(3):279-86. PubMed ID: 9138193 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]